Á¦52ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day1 : 2022-05-19±³À°ÀÏÀÚ : 2022-05-19
±³À°Àå¼Ò : È£ÅÚ ÀÎÅÍºÒ°í ´ë±¸, º»°ü 2Ãþ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
Á¦52ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ day1ÁÖÃÖ±â°ü : ´ëÇѼҾƽŰæÇÐȸ
´ã´çÀÚ : ÀÌÁö¿ø
¿¬¶ôó : 02-2019-3350
À̸ÞÀÏ :
kcnsped@nate.com ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 10:00~10:10 °³È¸»ç ³²»ó¿í(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 10:10~10:50 Surgical failure, what is next? Ki Hyeong Lee(AdventHealth Medical Group)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 10:50~11:30 Old antiepileptic medication vs. New antiseizure medication, which is better? ÀÌÁö¿ø / ¹Ú¼Ò¿µ(¼º±Õ°üÀÇ´ë / ¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 11:30~12:00 An update on NORSE and FIRES À̺¸·Ã(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 12:00~12:40 Treat or not_Should we treat interictal epileptiform discharges? ÇãÀ±Á¤ / ÀÌÀºÇý(ÀÎÁ¦ÀÇ´ë / °æÈñÀÇ´ë)
½Ä»ç 05-19 12:40~13:30 ½Ä»ç ()
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 13:30~13:40 Introduction and Case presentation of NF1 ¾öÅÂÈÆ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 13:40~14:05 Diagnosis and Clinical guideline of NF1 ±è¼¼À±(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 14:05~14:30 Radiologic findings of NF1 ÃÖ¿µÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 14:30~14:55 Treament of cutaneous lesions of NF1 ±èÁØ¿µ(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 14:55~15:20 Molecular pathophysiology and treatment of NF1 À̹üÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 15:20~15:30 Conclusion ¾öÅÂÈÆ(°¡Å縯ÀÇ´ë)
ÈÞ½Ä 05-19 15:30~15:50 ÈÞ½Ä ()
±³À°½Ã°£ 05-19 È£ÅÚ ÀÎÅͺҰí / ÄÁº¥¼ÇȦ 15:50~17:30 Oral presentation 1 (5ºÐ ¹ßÇ¥, 3ºÐ ÅäÀÇ / ÃÑ 13¿¬Á¦) ÁÂÀå: ±è¿ø¼· / ±è¿µÈÆ(ÃæºÏÀÇ´ë / °¡Å縯ÀÇ´ë)